FdaApplication
NDA 206439
Identifiers
- fda_app_no: NDA206439
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 2014-12-23 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;21MG | CAPSULE, EXTENDED RELEASE;ORAL |
| NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;7MG | CAPSULE, EXTENDED RELEASE;ORAL |
| NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;14MG | CAPSULE, EXTENDED RELEASE;ORAL |
| NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;28MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products